David E. Lanfear

175 papers receiving 4.3k citations

Hit Papers

The SGLT2 inhibitor canagliflozin in heart failure: the CHIEF-HF remote, patient-centered randomized trial 2022 · 158 citations
158201620262019202250100150200

Peers

David E. Lanfear
Comparison fields: 5 of 135
  • Cardiology and Cardiovascular Medicine 1.9k
  • Family Practice 170
  • Emergency Medicine 497
  • Endocrinology, Diabetes and Metabolism 516
  • Geriatrics and Gerontology 118
Replace Vasiliki V. Georgiopoulou with:
Vasiliki V. Georgiopoulou United States
Andrew P. Ambrosy United States
Savina Nodari Italy
Arend Mosterd Netherlands
Mona Fiuzat United States
Phillip D. Levy United States
Jasper J. Brugts Netherlands
Joseph Hung Australia
Kenneth Dickstein United States
Josep Lupón Spain
David E. Lanfear relative to Vasiliki V. Georgiopoulou United States Vasiliki V. Georgiopoulou's profile →
Citations per field
00.5×1.5×2.3×
Vasiliki V. Georgiopoulou · 1×
Citations per year

Countries citing papers authored by David E. Lanfear

Since Specialization
Citations

This map shows the geographic impact of David E. Lanfear's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Lanfear with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Lanfear more than expected).

Fields of papers citing papers by David E. Lanfear

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Lanfear. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Lanfear. The network helps show where David E. Lanfear may publish in the future.

Co-authors

The 25 scholars most cited alongside David E. Lanfear, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David E. Lanfear Line = papers co-authored together David E. Lanfear links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 182 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2011272
2
Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association
Hit paper breakdown →
2016239
3
The SGLT2 inhibitor canagliflozin in heart failure: the CHIEF-HF remote, patient-centered randomized trial
Hit paper breakdown →
2022158
4 2007140
5 2005133
6 2012123
7 2009106
8 2014102
9 200893
10 201389
11 201779
12 201678
13 201468
14 201867
15 201766
16 202262
17 201061
18 201461
19 201758
20 201657

About David E. Lanfear

David E. Lanfear is a scholar working on Family Practice, Cardiology and Cardiovascular Medicine, Emergency Medicine, Geriatrics and Gerontology and Transplantation, having authored 182 papers that have together received 4.4k indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (78 papers), Mechanical Circulatory Support Devices (41 papers), Cardiac Structural Anomalies and Repair (33 papers), Cardiovascular Function and Risk Factors (31 papers), Cardiac Arrest and Resuscitation (20 papers), Cardiac pacing and defibrillation studies (17 papers), Diabetes Treatment and Management (16 papers) and Potassium and Related Disorders (13 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (1.9k citations), Family Practice (170 citations), Emergency Medicine (497 citations), Endocrinology, Diabetes and Metabolism (516 citations) and Geriatrics and Gerontology (118 citations). David E. Lanfear has collaborated with scholars based in United States, Netherlands and Canada. Frequent co-authors include L. Keoki Williams, Karen Wells, Edward L. Peterson, Celeste T. Williams, John A. Spertus, Robert J. Brewer, Manel Pladevall, Jeffrey A. Morgan, Cristina Tita and Hassan Nemeh. Their work appears in journals such as Journal of Cardiac Failure, The Journal of Heart and Lung Transplantation, Circulation Heart Failure, Circulation and ASAIO Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026